Printer Friendly
The Free Library
14,815,112 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Alfresa Pharma Introduces New Stop-smoking Aid.


Tokyo, Japan, Aug 23, 2005 - (JCNN JCNN Japan Corporate News Network ) - Developed and manufactured by UK company Rosen Holdings, NicoBloc can substantially reduce the amount of nicotine nicotine, C10H14N2, poisonous, pale yellow, oily liquid alkaloid with a pungent odor and an acrid taste. It turns brown on exposure to air.  and tar smokers inhale in·hale
v.
1. To breathe in; inspire.

2. To draw something such as smoke or a medicinal mist into the lungs by breathing; inspire.
 by simply dropping the product on a cigarette. It can cut the amount by up to 99%.

Using natural ingredients, it does not change the taste of cigarettes while having no harmful effect on the body.

The company aims to generate sales of 50 million yen ($450,000) in the first year and 150 million yen ($1.3 mil) three years from now.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Aug 27, 2005
Words:105
Previous Article:Pfizer Japan Releases OTC Topical Drug.
Next Article:Matsushita, Intel to Co-develop Technology to Extend Laptop Life Using Next-Generation Battery.



Related Articles
WOULD-BE NONSMOKERS, DON'T BE DISCOURAGED.(L.A. LIFE)(Statistical Data Included)
Crews stop fire blowing toward I-5.(Fires)(Farm machinery sparks the grass fire near Creswell, which races toward the freeway and slows traffic with...
Novartis Pharma Announces Results of Smoking Cessation Survey.
AnGes MG to Start Phase I Clinical Trial of NF-kappa B Decoy Oligodeoxynucleotide for Atopic Dermatitis.
AnGes MG Finally Starts Phase I Clinical Trial of NF-kappa B Decoy Oligodeoxynucleotide for Atopic Dermatitis.
Alfresa Pharma to Become Distributor of Anafranil Antidepressant.
PULSE.(U)
Alfresa Pharma, Tanabe Seiyaku to Collaborate in Development and Sales of Narcolepsy Drug Modafinil.
Employer initiatives to stop smoking: as more employers take aggressive steps to reduce health care costs arising from employees' tobacco use, EAPs...
Novartis Pharma's Smoking Cessation Aid Nicotinell Now Conditionally Listed on Japan NHI Price List.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles